Anti-CD3E重组抗体|科研级 Visilizumab ( 维西珠单抗 )-Product Center-Tekbiotech-Yeast and Phage Display CRO, Expert in Nano-body and Antibody Drug Development

Anti-CD3E重组抗体|科研级 Visilizumab ( 维西珠单抗 )

Detailed related information Target background information Experimental Plan&FAQ Related products Recommended Services

询价与订购

Name*
Phone*
Email*
Product*
Content*

Anti-CD3E重组抗体|科研级 Visilizumab ( 维西珠单抗 )

instructions Contact

< >

CatNo：TKYR1046

Price

WeChat QR
Contact Us

instructions
MSDSWeChat QR
Contact Us

Detailed

Background

Plan&FAQ

Recommended

Detailed related information

Catalog Number

TKYR1046

Alias

科研级 Visilizumab ( 维西珠单抗 ), Anti-CD3E Recombinant Antibody, Research Grade Visilizumab

Molecular Name

Visilizumab

Size

1mg, 5mg

CAS Number

219716-33-3

Isotype

IgG2

Clonality

Monoclonal

Concentration

1mg/ml

Applications

ELISA, IHC, IF, IP, Flow Cyt, FuncS

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Target

CD3E[Homo sapiens]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Visilizumab (tentative trade name Nuvion, PDL BioPharma Inc.) is a humanized monoclonal antibody. It is being investigated for use as an immunosuppressive drug in patients with ulcerative colitis and Crohn's disease. Visilizumab binds to the CD3 receptor on certain activated T cells without affecting resting T cells. It is currently under clinical studies for the treatment of ulcerative colitis and Crohn's disease.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

Target background information

Experimental Plan&FAQ